Imidazo[1,3,5]triazinones and their use

US7091203B2 · kind B2 · utility

Assignee

• BAYER HEALTHCARE LLC · DE

Inventors

• Ulrich Niewohner · Wermelskirchen, DE
• Helmut Haning · Milford, US
• Thomas Lampe · Mülheim an der Ruhr, DE
• Mazen Es-Sayed · Langenfeld, DE
• Gunter Schmidt · Houghton, US
• Erwin Bischoff · Wuppertal, DE
• Klaus Dembowsky · Boston, US
• Elisabeth Perzborn · Wuppertal, DE
• Karl-Heinz Schlemmer · Wuppertal, DE

Key dates

• Filing date: Jul 15, 2004
• Grant date: Aug 15, 2006
• Expiry date: Sep 18, 2024

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to imidazo[1,3,5]triazinones, a method for their production and methods of use, in particular as inhibitors of cyclic GMP metabolizing phosphodiesterases.